MartÃnez-Vila, C.; González-Navarro, E.A.; Teixido, C.; Martin, R.; Aya, F.; Juan, M.; Arance, A.
Lymphocyte T Subsets and Outcome of Immune Checkpoint Inhibitors in Melanoma Patients: An Oncologist’s Perspective on Current Knowledge. Int. J. Mol. Sci. 2024, 25, 9506.
https://doi.org/10.3390/ijms25179506
AMA Style
MartÃnez-Vila C, González-Navarro EA, Teixido C, Martin R, Aya F, Juan M, Arance A.
Lymphocyte T Subsets and Outcome of Immune Checkpoint Inhibitors in Melanoma Patients: An Oncologist’s Perspective on Current Knowledge. International Journal of Molecular Sciences. 2024; 25(17):9506.
https://doi.org/10.3390/ijms25179506
Chicago/Turabian Style
MartÃnez-Vila, Clara, Europa Azucena González-Navarro, Cristina Teixido, Roberto Martin, Francisco Aya, Manel Juan, and Ana Arance.
2024. "Lymphocyte T Subsets and Outcome of Immune Checkpoint Inhibitors in Melanoma Patients: An Oncologist’s Perspective on Current Knowledge" International Journal of Molecular Sciences 25, no. 17: 9506.
https://doi.org/10.3390/ijms25179506
APA Style
MartÃnez-Vila, C., González-Navarro, E. A., Teixido, C., Martin, R., Aya, F., Juan, M., & Arance, A.
(2024). Lymphocyte T Subsets and Outcome of Immune Checkpoint Inhibitors in Melanoma Patients: An Oncologist’s Perspective on Current Knowledge. International Journal of Molecular Sciences, 25(17), 9506.
https://doi.org/10.3390/ijms25179506
